1
|
Gee S, Nelson N, Bornot A, Carter N, Cuomo ME, Dovedi SJ, Smith PD, Gianni D, Baker DJ. Developing an Arrayed CRISPR-Cas9 Co-Culture Screen for Immuno-Oncology Target ID. SLAS Discov 2020; 25:581-590. [PMID: 32375580 DOI: 10.1177/2472555220916457] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
Abstract
Immunotherapies including PD-L1 blockade have shown remarkable increases in the T cell-directed antitumor response; however, efficacy is seen only in a minority of patients. Recently, pooled CRISPR-Cas9 knockout (CRISPRn) screens in tumor/immune co-culture systems have identified a number of genes that confer resistance to T cell killing in pathways including antigen presentation and cytokine signaling, providing insight into tumor mechanisms that cause resistance to immunotherapies. The development of an arrayed CRISPRn screen in a tumor/immune co-culture system would allow the identification of novel targets for immuno-oncology, characterization of hits from pooled screens, and multiple assay endpoints to be measured per gene. Here, a small-scale arrayed CRISPRn screen was successfully developed to investigate the effects on a co-culture of T cells and Cas9-expressing PC9 lung adenocarcinoma cells modified to express anti-CD3 antibody on the cell surface (PC9-OKT3 T cell system). A focused CRISPRn library was designed to target genes involved in known resistance mechanisms (including antigen presentation, cytokine signaling, and apoptosis) as well as genes involved in immune synapse interactions. The viability of PC9 cells was assessed in two-dimensional adherent co-cultures via longitudinal imaging analysis. Knockout of epidermal growth factor receptor (EGFR) and PLK1 in tumor cells cultured alone or with T cells resulted in increased tumor cell death, as expected, whereas knockout of the test gene ICAM1 showed subtle donor-specific resistance to T cell killing. Taken together, these data provide proof of concept for arrayed CRISPRn screens in tumor/immune co-culture systems and warrant further investigation of in vitro co-culture models.
Collapse
Affiliation(s)
- Sarah Gee
- Discovery Biology, Discovery Sciences, R&D, AstraZeneca, Cambridge, UK
| | - Nadine Nelson
- Oncology R&D, AstraZeneca, Cambridge, Cambridgeshire, UK
| | - Aurelie Bornot
- Quantitative Biology, Discovery Sciences, R&D, AstraZeneca, Cambridge, UK
| | - Nikki Carter
- Discovery Biology, Discovery Sciences, R&D, AstraZeneca, Cambridge, UK
| | | | - Simon J Dovedi
- Oncology R&D, AstraZeneca, Cambridge, Cambridgeshire, UK
| | - Paul D Smith
- Oncology R&D, AstraZeneca, Cambridge, Cambridgeshire, UK
| | - Davide Gianni
- Discovery Biology, Discovery Sciences, R&D, AstraZeneca, Cambridge, UK
| | - David J Baker
- Discovery Biology, Discovery Sciences, R&D, AstraZeneca, Cambridge, UK
| |
Collapse
|
2
|
Kit Y, Magorivska I, Bilyi R, Myronovskij S, Stoika R. Anti-histone H1 IgGs possess proliferative activity towards human T-leukaemia CEM cells. Exp Oncol 2017; 39:36-41. [PMID: 28361854] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/07/2023]
Abstract
UNLABELLED The aim of this study was to characterize the proliferative activity of the anti-histone H1 IgGs towards human T-leukaemia CEM cells. MATERIALS AND METHODS Anti-histone H1 IgGs were purified from blood serum of systemic lupus erythematosus patients by precipitation of serum proteins with 50% ammonium sulfate followed by a sequential affinity chromatography on Protein G-Sepharose and histone H1-Sepharose columns. To avoid contamination with other proteins, anti-histone H1 IgGs were subjected to strongly acidic pH 2.0 during gel filtration through HPLC column. The effects of the anti-histone H1 IgGs on cell viability and cell cycle were tested by MTS-assay and flow cytometry, correspondingly. The cross-reactivity of the anti-histone H1 antibodies towards heterogenetic and cellular antigens was evaluated by Western-blot analysis. RESULTS It was found that incubation of CEM cells with the HPLC-purified anti-histone H1 IgGs resulted in significant stimulation of cell growth by 46% after 48 h of incubation. These IgGs possess an antigenic poly-specificity to positively charged heterogenetic antigens and different cellular antigens. FITC-labeled and biotinylated anti-histone H1 IgGs are internalized by CEM cells and preferentially accumulated in the cytoplasm. CONCLUSION The anti-histone H1 IgGs are shown to internalize human T-leukemia CEM and stimulate their proliferation. These IgGs are polyspecific toward cellular antigens.
Collapse
MESH Headings
- Antibodies, Anti-Idiotypic/isolation & purification
- Antibodies, Anti-Idiotypic/metabolism
- Antibodies, Anti-Idiotypic/pharmacology
- Antibody Affinity/immunology
- Antibody Specificity/immunology
- Blotting, Western
- Cell Cycle/drug effects
- Cell Line, Tumor
- Cell Proliferation/drug effects
- Cell Survival/drug effects
- Chromatography, Affinity
- Chromatography, Gel
- Cross Reactions/immunology
- Cytoplasm/metabolism
- Histones/immunology
- Humans
- Leukemia, T-Cell/immunology
- Leukemia, T-Cell/metabolism
- Leukemia, T-Cell/pathology
- Lupus Erythematosus, Systemic/blood
- Lupus Erythematosus, Systemic/immunology
Collapse
Affiliation(s)
- Y Kit
- Institute of Cell Biology, National Academy of Sciences of Ukraine, Lviv 79005, Ukraine
| | - I Magorivska
- Institute of Cell Biology, National Academy of Sciences of Ukraine, Lviv 79005, Ukraine
| | - R Bilyi
- Danylo Halytsky Lviv National Medical University, Lviv 79010, Ukraine
| | - S Myronovskij
- Institute of Cell Biology, National Academy of Sciences of Ukraine, Lviv 79005, Ukraine
| | - R Stoika
- Institute of Cell Biology, National Academy of Sciences of Ukraine, Lviv 79005, Ukraine
| |
Collapse
|
3
|
Siebert N, Eger C, Seidel D, Jüttner M, Lode HN. Validated detection of human anti-chimeric immune responses in serum of neuroblastoma patients treated with ch14.18/CHO. J Immunol Methods 2014; 407:108-15. [PMID: 24727144 DOI: 10.1016/j.jim.2014.04.001] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/29/2014] [Revised: 04/01/2014] [Accepted: 04/01/2014] [Indexed: 11/18/2022]
Abstract
Human/mouse chimeric monoclonal antibody (mAb) ch14.18/CHO is directed against disialoganglioside GD2. Activity and efficacy of this mAb are currently determined in ongoing clinical Phase II and -III studies in high-risk neuroblastoma (NB). Based on the chimeric nature of this mAb, some patients may develop a human anti-chimeric immune response (Mirick et al., 2004) which impacts on pharmacokinetics and may induce anti-anti-idiotype (Id) mAb with a potential survival benefit. Therefore, a validated method of quantitative detection of human anti-chimeric antibodies (HACA) in serum samples of NB patients treated with ch14.18/CHO is an important tool for monitoring of clinical trials. Here, we report a validated sandwich enzyme-linked immunosorbent assay (ELISA) according to the one arm binding principle using ch14.18/CHO as a capture mAb and biotinylated ch14.18/CHO mAb for detection. Ganglidiomab, a monoclonal anti-Id Ab to ch14.18/CHO (Lode et al., 2013), was used as a standard for assay validation and HACA quantification. Systematic evaluation of the established ELISA procedure revealed an optimal serum sample dilution factor of 1:160. Assay validation was accomplished with a set of tailored quality controls (QC) containing distinct concentrations of ganglidiomab (3 and 15μg/ml). The coefficients of variation (CV) for all within-assay and inter-assay measurements using QCs were under 20% and the limit of detection (LOD) was 1.1μg/ml. Three patients (P1, P2, P3) treated with a 10day continuous infusion of 100mg/m(2) of ch14.18/CHO were selected for analysis with this assay. Selection was based on ch14.18/CHO drug level on day 8 in cycle 2 of >10μg/ml (expected) (P1) and of <2μg/ml (unexpected) (P2 and P3). Both patients with unexpected low ch14.18/CHO levels revealed a strong signal in the HACA ELISA. Interestingly, ch14.18/CHO-mediated complement-dependent cytotoxicity (CDC) could not be detected in P2 in contrast to P3 suggesting anti-NB activity even in the presence of HACA. We showed that neither eight freeze-thaw cycles nor storage at room temperature for up to 168h affected HACA stability in serum. In summary, we describe a validated ELISA method suitable for the assessment of HACA in NB patients treated with ch14.18/CHO.
Collapse
Affiliation(s)
- Nikolai Siebert
- Department of Pediatric Oncology and Hematology, University Medicine Greifswald, 17475 Greifswald, Germany.
| | - Christin Eger
- Department of Pediatric Oncology and Hematology, University Medicine Greifswald, 17475 Greifswald, Germany.
| | - Diana Seidel
- Department of Pediatric Oncology and Hematology, University Medicine Greifswald, 17475 Greifswald, Germany.
| | - Madlen Jüttner
- Department of Pediatric Oncology and Hematology, University Medicine Greifswald, 17475 Greifswald, Germany.
| | - Holger N Lode
- Department of Pediatric Oncology and Hematology, University Medicine Greifswald, 17475 Greifswald, Germany.
| |
Collapse
|
4
|
Wang D, Xu Y, Tu Z, Fu JH, Xiong YH, Feng F, Tao Y, Lei D. Isolation and characterization of recombinant variable domain of heavy chain anti-idiotypic antibodies specific to aflatoxin B1. Biomed Environ Sci 2014; 27:118-121. [PMID: 24625402 DOI: 10.3967/bes2014.025] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Received: 06/17/2013] [Accepted: 11/16/2013] [Indexed: 06/03/2023]
Abstract
Some unique subclasses of Camelidae antibodies are devoid of the light chain, and the antigen binding site is comprised exclusively of the variable domain of the heavy chain (VHH). The recombinant VHHs have a high potential as alternative reagents for the next generation of immunoassay. In particular, they might be very useful for molecular mimicry. The present study demonstrated an alpaca immunized with the F(ab')2 fragment of anti-aflatoxin B1 mAb and developed an important anti-idiotypic (anti-Id) responses. Antigen-specific elution method was used for panning private anti-Id VHHs from the constructed alpaca VHH library. The selected VHHs were expressed, renatured, purified, and then identified by a competitive enzyme-linked immunosorbent assay (ELISA). Our findings indicated that the VHH would be an alternative tool for haptens mimicry studies.
Collapse
Affiliation(s)
- Dan Wang
- State Key Laboratory of Food Science and Technology, Nanchang University, Nanchang 330047, Jiangxi, China
| | - Yang Xu
- State Key Laboratory of Food Science and Technology, Nanchang University, Nanchang 330047, Jiangxi, China; Jiangxi-OAI Joint Research Institute, Nanchang University, Nanchang 330047, Jiangxi, China
| | - Zhui Tu
- State Key Laboratory of Food Science and Technology, Nanchang University, Nanchang 330047, Jiangxi, China; Jiangxi-OAI Joint Research Institute, Nanchang University, Nanchang 330047, Jiangxi, China
| | - Jin Heng Fu
- Jiangxi-OAI Joint Research Institute, Nanchang University, Nanchang 330047, Jiangxi, China
| | - Yong Hua Xiong
- State Key Laboratory of Food Science and Technology, Nanchang University, Nanchang 330047, Jiangxi, China; Jiangxi-OAI Joint Research Institute, Nanchang University, Nanchang 330047, Jiangxi, China
| | - Fan Feng
- State Key Laboratory of Food Science and Technology, Nanchang University, Nanchang 330047, Jiangxi, China; Jiangxi-OAI Joint Research Institute, Nanchang University, Nanchang 330047, Jiangxi, China
| | - Yong Tao
- Jiangxi-OAI Joint Research Institute, Nanchang University, Nanchang 330047, Jiangxi, China
| | - Da Lei
- State Key Laboratory of Food Science and Technology, Nanchang University, Nanchang 330047, Jiangxi, China; Jiangxi-OAI Joint Research Institute, Nanchang University, Nanchang 330047, Jiangxi, China
| |
Collapse
|
5
|
Li W, Lan H, Liu H, Fu Z, Yang Y, Han W, Guo F, Liu Y, Zhang H, Liu J, Zheng X. The activation and differential signalling of the growth hormone receptor induced by pGH or anti-idiotypic monoclonal antibodies in primary rat hepatocytes. Mol Cell Endocrinol 2013; 376:51-9. [PMID: 23769824 DOI: 10.1016/j.mce.2013.06.008] [Citation(s) in RCA: 21] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 12/18/2012] [Revised: 06/04/2013] [Accepted: 06/07/2013] [Indexed: 10/26/2022]
Abstract
In this report, we have developed a panel of monoclonal anti-idiotypic antibodies to pGH by immunising BALB/c mice with a purified monoclonal anti-pGH antibody (1A3), among which one mAb, termed CG-8F, was selected for further characterisation. We found that CG-8F behaved as a typical Ab2β, not only conformationally competing with pGH for 1A3 but also exhibiting recognition for GHR in a rat hepatocyte model. We next examined the resulting signal transduction pathways triggered by this antibody in rat hepatocytes and found that both pGH and CG-8F could trigger the JAK2-STAT1/3/5-mediated signal transduction pathway. Furthermore, the phosphorylation kinetics of pSTAT1/3/5 induced by either pGH or CG-8F were remarkably similar in the dose-response and time course rat hepatocyte experiments. In contrast, only pGH, but not CG-8F, was capable of inducing ERK phosphorylation. Further experimental studies indicated that the two functional binding sites on CG-8F are required for GHR activation. This study partially reveals the mechanism of action of GH anti-idiotypic antibodies and also indicates that monoclonal anti-idiotypic antibodies represent an effective way to produce GH mimics, suggesting that it is possible to produce signal-specific cytokine agonists using an anti-idiotypic antibody approach.
Collapse
MESH Headings
- Animals
- Animals, Newborn
- Antibodies, Anti-Idiotypic/biosynthesis
- Antibodies, Anti-Idiotypic/isolation & purification
- Antibodies, Anti-Idiotypic/pharmacology
- Antibodies, Monoclonal/biosynthesis
- Antibodies, Monoclonal/isolation & purification
- Antibodies, Monoclonal/pharmacology
- Gene Expression Regulation
- Growth Hormone/metabolism
- Growth Hormone/pharmacology
- Hepatocytes/cytology
- Hepatocytes/drug effects
- Hepatocytes/metabolism
- Janus Kinase 2/genetics
- Janus Kinase 2/metabolism
- Liver/cytology
- Liver/drug effects
- Liver/metabolism
- Mice
- Mice, Inbred BALB C
- Phosphorylation
- Primary Cell Culture
- Rats
- Rats, Wistar
- Receptors, Somatotropin/genetics
- Receptors, Somatotropin/metabolism
- STAT1 Transcription Factor/genetics
- STAT1 Transcription Factor/metabolism
- STAT3 Transcription Factor/genetics
- STAT3 Transcription Factor/metabolism
- STAT5 Transcription Factor/genetics
- STAT5 Transcription Factor/metabolism
- Signal Transduction/drug effects
Collapse
Affiliation(s)
- Wei Li
- College of Animal Science and Technology, Jilin Agricultural University, Changchun 130118, PR China
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|
6
|
Kurova NN, Tseneva GI, Zhebrun AB. [Anti-pertussis immunity in children in the cities of Northwestern Federal District with various population]. Zh Mikrobiol Epidemiol Immunobiol 2013:33-37. [PMID: 24341212] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/03/2023]
Abstract
AIM Evaluate the state of immunity against pertussis in children living in St. Petersburg and regional centers of Northwestern Federal District (NFD). MATERIALS AND METHODS The level of anti-pertussis antibodies by EIA and agglutinin reaction (AR) was studied in 419 children living in St. Petersburg and by AR in 239 children living in regional centers of NFD. Blood sera in AR were studied by using liquid pertussis diagnosticum (Biomed, Russia). RESULTS In St. Petersburg the frequency of detection of high level of antibodies was the highest in the 15 - 17 age group that indicates a high level of latent morbidity in grownups. The frequency of detection of high level of antibodies in the 3 - 4 and 9 - 10 age groups in regional centers was significantly lower, and the fraction of sera with undetected level of antibodies--significantly higher compared with St. Petersburg, that gives evidence on low circulation of causative agent, lack of "epidemizing" of children in small cities. CONCLUSION The question of introduction of second revaccination against pertussis in children at the age of 6 is actual, because one vaccination is not enough for prolonged sustaining of population immunity intensity.
Collapse
|
7
|
Abstract
BACKGROUND The epidemiology of Toxocara infection in humans in Mexico has been poorly explored. There is a lack of information about Toxocara infection in waste pickers. AIMS Determine the seroepidemiology of Toxocara infection in waste pickers. METHODS Through a case control study design, the presence of anti-Toxocara IgG antibodies was determined in 90 waste pickers and 90 age- and gender-matched controls using an enzyme-linked immunoassay. Associations of Toxocara exposure with socio-demographic, work, clinical, and behavioral data of the waste pickers were also evaluated. RESULTS The seroprevalence of anti-Toxocara IgG antibodies was significantly higher in waste pickers (12/90: 13%) than in control subjects (1/90: 1%) (OR = 14; 95% CI: 2-288). The seroprevalence was not influenced by socio-demographic or work characteristics. In contrast, increased seroprevalence was found in waste pickers suffering from gastritis, and reflex and visual impairments. Multivariate analysis showed that Toxocara exposure was associated with a low frequency of eating out of home (OR = 26; 95% CI: 2-363) and negatively associated with consumption of chicken meat (OR = 0.03; 95% CI: 0.003-0.59). Other behavioral characteristics such as animal contacts or exposure to soil were not associated with Toxocara seropositivity. CONCLUSIONS 1) Waste pickers are a risk group for Toxocara infection. 2) Toxocara is impacting the health of waste pickers. This is the first report of Toxocara exposure in waste pickers and of associations of gastritis and reflex impairment with Toxocara seropositivity. Results warrant for further research.
Collapse
Affiliation(s)
- Cosme Alvarado-Esquivel
- Department of Infectology, Faculty of Medicine and Nutrition, Juárez University of Durango State, Durango, Mexico.
| |
Collapse
|
8
|
Sturgill JL, Conrad DH. Purifying and measuring immunoglobulin E (IgE) and anti-IgE. Methods Mol Biol 2013; 1032:121-131. [PMID: 23943448 DOI: 10.1007/978-1-62703-496-8_9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/02/2023]
Abstract
Immunoglobulins (Igs) are a critical component of the adaptive immune system of both man and mouse. The ability to detect and characterize Igs is an invaluable technique for immunology in either a research or a clinical setting. The advent of enzyme-linked immunosorbent assays (ELISAs) and monoclonal antibody technology has proven instrumental for advancing the science of Ig biology. IgE is of interest as it is the primary Ig responsible for allergic reactions ranging from allergic rhinitis to anaphylaxis. Here, we describe the history behind the IgE discovery and the protocol for purifying IgE and anti-IgE in the mouse. This is followed by our ELISA protocol for mouse IgE detection.
Collapse
Affiliation(s)
- Jamie L Sturgill
- Department of Microbiology and Immunology, Virginia Commonwealth University School of Medicine, Richmond, VA, USA
| | | |
Collapse
|
9
|
Smirnov I, Belogurov A, Friboulet A, Masson P, Gabibov A, Renard PY. Strategies for the selection of catalytic antibodies against organophosphorus nerve agents. Chem Biol Interact 2012; 203:196-201. [PMID: 23123255 DOI: 10.1016/j.cbi.2012.10.011] [Citation(s) in RCA: 19] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/07/2012] [Revised: 10/12/2012] [Accepted: 10/16/2012] [Indexed: 01/25/2023]
Abstract
Among the strategies aimed at biocompatible means for organophosphorus nerve agents neutralization, immunoglobulins have attracted attention in the 1990's and 2000's both for their ability to immobilize the toxicants, but also for their ability to be turned into enzymatically active antibodies known as catalytic antibodies or abzymes (antibodies--enzymes). We will present here a critical review of the successive strategies used for the selection of these nerve agent-hydrolyzing abzymes, based on hapten design, namely antibodies raised against a wide variety of transition state analogs, and eventually the strategies based on anti-idiotypic antibodies and reactibodies.
Collapse
Affiliation(s)
- Ivan Smirnov
- MM Shemyakin and Yu.A. Ovchinnikov Institute of Bioorganic Chemistry RAS, Moscow, Russia
| | | | | | | | | | | |
Collapse
|
10
|
Zhang YX, Wang BC, Yu X, Dai YJ, He YZ, Cong C, Xia Y, Wang MR. [Ribosome display screening of a novel human anti-IgE scFv fragment]. Yao Xue Xue Bao 2012; 47:1329-1335. [PMID: 23289145] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/01/2023]
Abstract
Total mRNA was extracted from lymphocytes separated from the peripheral blood of allergic patients, and then variable region of heavy chain (VH) and variable region of light chain (VL) cDNA library were constructed by RT-PCR. Human scFv templates for rabbit reticulocyte lysate ribosome display were assembled by primers and linker peptide (Gly4Ser)3. mRNA bound in antibody-ribosome-mRNA complexes was recovered using in-situ single primer RT-PCR, and three rounds of anti-IgE scFv DNA were enriched. The target DNA fragments were double enzyme digested and ligated into plasmid pET22b (+), followed by transformation in E. coli Rosseta (DE3). Positive clones were screened using clone PCR, Dot blotting and antigen ELISA. The correct lengths of VH (400 bp) and VL (710 bp) PCR products were obtained. The expected 1,000 bp ribosome display templates were also observed in agarose gel electrophoresis. After three rounds of ribosome display target sequences were effectively enriched, leading to a library of 10(13) members. Antibodies with the highest ELISA value for IgE were generated in the strain pET-IgE-6. A human anti-IgE scFv library was successfully constructed as described herein. Ribosome display using single primer in-situ RT-PCR as the recovery procedure effectively enriched target sequences. Anti-IgE scFv with high affinity and specificity were identified. The prepared human anti-IgE scFv fragment might be self-developed to a lead drug for treating asthma. Our study provides an alternative method for rapid discovery of human antibodies of therapeutic importance.
Collapse
Affiliation(s)
- Yong-xia Zhang
- Chengdu Institute of Biological Products Co., Ltd., Chengdu, China
| | | | | | | | | | | | | | | |
Collapse
|
11
|
Palmer DS, O'Toole J, Montreuil T, Scalia V, Goldman M. Evaluation of particle gel immunoassays for the detection of severe immunoglobulin A deficiency and anti-human immunoglobulin A antibodies. Transfusion 2012; 52:1792-8. [PMID: 22229448 DOI: 10.1111/j.1537-2995.2011.03513.x] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
Abstract
BACKGROUND Immunoglobulin A (IgA)-deficient patients with anti-IgA (Ab) require transfusions using blood components with less than 0.05 mg IgA/dL as they are known to be safe for these patients. Identification of severely IgA-deficient (IgA SD) donors involved preliminary screening by the Ouchterlony double immunodiffusion assay followed by confirmatory testing at the required level of sensitivity for IgA and Ab at an external reference laboratory. Two in vitro particle gel immunoassays (ID-PaGIA IgA deficiency test and anti-IgA test) were also evaluated for their suitability in identifying IgA SD individuals and determining their Ab status. STUDY DESIGN AND METHODS Samples from 198 donors and 36 patients, subjected to confirmatory testing for IgA SD and Ab over a 2-year period, were also evaluated using the ID-PaGIA kits. RESULTS DiaMed test sensitivity and specificity for detection of IgA SD in donors was 98% whereas for Ab, test sensitivity was 91% at a specificity of 94%. In patients, sensitivity was 94% for IgA SD and 67% for Ab, both tests at a specificity of 100%. CONCLUSIONS The ID-PaGIA IgA deficiency test was a sensitive and specific tool for identifying IgA SD donors or patients. Sensitivity of the Ab test was high for donors but reduced for patients and of high specificity in both groups. Further studies with patients are needed to confirm this latter observation. Implementation of these tests would make it possible to supply appropriate products from IgA SD donors to prevent anaphylactic transfusion reactions in patients.
Collapse
Affiliation(s)
- Douglas S Palmer
- National Testing Laboratory and Donor and Transplantation Services, Head Office, Canadian Blood Services, Ottawa, Ontario, Canada.
| | | | | | | | | |
Collapse
|
12
|
Xu J, Zhu XJ, Li YH, Dai Y, Zhu YC, Zheng J, Feng ZQ, Guan XH. Expression, characterization and therapeutic efficacy of chimeric Fab of anti-idiotypic antibody NP30 against Schistosoma japonicum. Acta Trop 2011; 118:159-64. [PMID: 21376700 DOI: 10.1016/j.actatropica.2011.01.006] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/31/2010] [Revised: 01/20/2011] [Accepted: 01/21/2011] [Indexed: 11/15/2022]
Abstract
The murine monoclonal anti-idiotypic antibody NP30 is a promising therapeutic antibody against Schistosoma japonicum. However, the immunogenicity of murine NP30 limits its further study and application in humans. Here the chimeric Fab of NP30 (chFab-NP30) comprising the variable regions of murine NP30 and constant regions of human antibody was assembled. chFab-NP30 was expressed and purified as a soluble and functional protein. Administration of chFab-NP30 in vivo increased the survival rate, reduced egg burdens and ameliorated organ pathology of mice with acute schistosomiasis. Our study indicated that chFab-NP30 is a promising candidate to be used as a specific and efficient recombinant antibody against acute schistosomiasis japonica. Further studies on function mechanism of chFab-NP30 needs to be carried out in the future.
Collapse
Affiliation(s)
- Jing Xu
- Key Lab of Antibody Technique of Ministry of Health, Nanjing Medical University, China
| | | | | | | | | | | | | | | |
Collapse
|
13
|
Lee G, Ge B. Inhibition of in vitro tumor cell growth by RP215 monoclonal antibody and antibodies raised against its anti-idiotype antibodies. Cancer Immunol Immunother 2010; 59:1347-56. [PMID: 20473495 PMCID: PMC11030551 DOI: 10.1007/s00262-010-0864-7] [Citation(s) in RCA: 13] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/29/2009] [Accepted: 04/27/2010] [Indexed: 10/24/2022]
Abstract
RP215 monoclonal antibody (Mab) was shown to recognize carbohydrate-associated epitope(s) in the heavy chains of cancer cell-expressed immunoglobulins, designated in general as CA215 pan cancer marker. Growth inhibitions of tumor cells in vitro by RP215 Mab and antibodies against its anti-idiotype (anti-id) antibodies were investigated. Polyclonal rabbit anti-id antibodies and the corresponding rat anti-id Mabs were generated and characterized. Following immunizations in mice, antisera raised against anti-id antibodies were analyzed by typical immunoassays. It was observed that mouse anti-anti-id sera (Ab3) revealed binding affinity and specificity to CA215 that are comparable to those of RP215. Both RP215 and Ab3 were shown to induce apoptosis of cultured cancer cells in vitro by TUNEL and MTT assays. These experimental observations were consistent with that of in vivo tumor growth inhibition by RP215 in previous nude mouse experiments. Therefore, heterologous or homologous anti-id antibodies of RP215 that contain the internal image of its specific epitope in CA215 may serve as effective anti-cancer vaccines for therapeutic treatments of various cancers in humans. The relative stability of RP215-specific carbohydrate-associated epitope was compared to that of human IgG at extreme pH's (or=12) or following NaIO(4) treatments. The major molecular forms of CA215 were further documented with various enzyme immunoassays and found to have similar secondary structures to those of normal human immunoglobulin G.
Collapse
Affiliation(s)
- Gregory Lee
- UBC Center for Reproductive Health, The University of British Columbia, Vancouver, BC, Canada.
| | | |
Collapse
|
14
|
Shimbo T, Tanemura A, Yamazaki T, Tamai K, Katayama I, Kaneda Y. Serum anti-BPAG1 auto-antibody is a novel marker for human melanoma. PLoS One 2010; 5:e10566. [PMID: 20479946 PMCID: PMC2866734 DOI: 10.1371/journal.pone.0010566] [Citation(s) in RCA: 22] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/06/2010] [Accepted: 04/19/2010] [Indexed: 01/12/2023] Open
Abstract
Malignant melanoma is one of the most aggressive types of tumor. Because malignant melanoma is difficult to treat once it has metastasized, early detection and treatment are essential. The search for reliable biomarkers of early-stage melanoma, therefore, has received much attention. By using a novel method of screening tumor antigens and their auto-antibodies, we identified bullous pemphigoid antigen 1 (BPAG1) as a melanoma antigen recognized by its auto-antibody. BPAG1 is an auto-antigen in the skin disease bullous pemphigoid (BP) and anti-BPAG1 auto-antibodies are detectable in sera from BP patients and are used for BP diagnosis. However, BPAG1 has been viewed as predominantly a keratinocyte-associated protein and a relationship between BPAG1 expression and melanoma has not been previously reported. In the present study, we show that bpag1 is expressed in the mouse F10 melanoma cell line in vitro and F10 melanoma tumors in vivo and that BPAG1 is expressed in human melanoma cell lines (A375 and G361) and normal human melanocytes. Moreover, the levels of anti-BPAG1 auto-antibodies in the sera of melanoma patients were significantly higher than in the sera of healthy volunteers (p<0.01). Furthermore, anti-BPAG1 auto-antibodies were detected in melanoma patients at both early and advanced stages of disease. Here, we report anti-BPAG1 auto-antibodies as a promising marker for the diagnosis of melanoma, and we discuss the significance of the detection of such auto-antibodies in cancer biology and patients.
Collapse
Affiliation(s)
- Takashi Shimbo
- Division of Gene Therapy Science, Osaka University Graduate School of Medicine, Osaka, Japan
| | - Atsushi Tanemura
- Department of Dermatology, Osaka University Graduate School of Medicine, Osaka, Japan
| | - Takehiko Yamazaki
- Division of Gene Therapy Science, Osaka University Graduate School of Medicine, Osaka, Japan
| | - Katsuto Tamai
- Division of Gene Therapy Science, Osaka University Graduate School of Medicine, Osaka, Japan
| | - Ichiro Katayama
- Department of Dermatology, Osaka University Graduate School of Medicine, Osaka, Japan
| | - Yasufumi Kaneda
- Division of Gene Therapy Science, Osaka University Graduate School of Medicine, Osaka, Japan
| |
Collapse
|
15
|
Abstract
During the period 1976-83, anti-mitochondrial antibodies (AMA) were detected in 68 patients out of about 48 000 sera (0.14%) analyzed for a repertoire of autoantibodies at the Department of Immunology, University Hospital of Tromsø. Fifty-five of these patients were women, and only 10 had unequivocal primary biliary cirrhosis (PBC). At follow-up in 1984, 48 out of these 68 patients were accessible for complementary testing. The AMA test became negative in 17 of these 48 patients during the observation period. Eleven of these 17 had originally a titer of 50. Seven of the 31 patients with persistent AMA were without detectable liver pathology. One patient had antibodies against smooth muscle, one against cell nucleus, whereas 35 had an increased serum IgM level. In conclusion, most patients with AMA do not have obvious PBC, a low AMA titer is likely to be transient, and there is a strong association between AMA and an increased serum IgM level.
Collapse
|
16
|
Tornetta M, Fisher D, O'Neil K, Geng D, Schantz A, Brigham-Burke M, Lombardo D, Fink D, Knight D, Sweet R, Tsui P. Isolation of human anti-idiotypic antibodies by phage display for clinical immune response assays. J Immunol Methods 2007; 328:34-44. [PMID: 17888945 DOI: 10.1016/j.jim.2007.08.008] [Citation(s) in RCA: 19] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/12/2005] [Revised: 05/23/2007] [Accepted: 08/02/2007] [Indexed: 11/29/2022]
Abstract
The clinical development of therapeutic proteins requires assays that measure the pharmacokinetic (PK) profile of, and the potential immune response (IR) to, the protein agent. Each assay requires reagents that are highly specific for the therapeutic protein. For therapeutic monoclonal antibodies, anti-CDR-specific, or anti-idiotypic (anti-id), antibodies are an ideal class of reagents suitable for these assays because of their high specificity and affinity to the drug antibody. We generated anti-ids to two human antibodies by antibody phage display using the MorphoSys HuCAL GOLD Fab library. To selectively target the CDR regions, serum and a framework-matched mAb were included as competitors during the phage selection process. Panels of CDR-specific Fabs, with low to sub-nM affinities, were isolated against both targets. The CDR specificity of these Fabs was shown by their lack of binding to a framework-matched control mAb and by competition of this binding with the soluble antigens of the respective therapeutic mAb targets. The candidate anti-id Fabs were able to detect both immobilized and soluble target Ab without being affected by serum, a requirement for both PK assay and the IR bridging assay format. Combinations of the Fabs for PK detection assays were identified by pairwise binding studies, although the pair for one target mAb lacks the desired sensitivity for PK assays. To evaluate their potential as anti-drug antibodies (ADAs), the best Fabs for one of the targets were converted and produced as the required bivalent human mAbs. In comparison to rodent mAbs and primate polyclonal serum, the phage display derived human mAbs were equally effective as reference standards. Our results demonstrate that competition-based phage selection can be an effective method for the isolation of anti-idiotypic antibodies for PK and IR assay development, and in this latter case, overcome limitations of current methods using rodent derived anti-ids.
Collapse
Affiliation(s)
- M Tornetta
- Department of Molecular Discovery Technologies, Centocor Inc, Radnor, PA, USA.
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|
17
|
Zhao LX, Yan B, Xu L, Jiang SW, Zhang YY, Yang ZX, Zhou XW, Huang PT. [Expression, purification and activity analysis of anti-human transferrin receptor scFv]. Sheng Wu Gong Cheng Xue Bao 2006; 22:488-91. [PMID: 16755932] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/10/2023]
Abstract
Human transferrin receptor (TfR) was isolated from homogenates of placental tissues by affinity chromatography on transferrin-Sepharose, and then used to screen human scFv against it from a fully-synthesized phage scFv library. After verifying the specificity, gene fragment of one of the selected scFv was inserted into the plasmid pET22b(+) and transformed into E. coli BL21(DE3) . Expression of scFv in transformant was induced with 0.5mmol/L IPTG. ELISA assay on HeLa cells showed that scFv protein could recognize and bind to TfR on the surface of HeLa cells. The scFv was purified by one-step affinity chromatography with Ni+ -NTA agarose, and injected into Kunming mouse via tail veins. This scFv was detected in brain tissues 1h later by capillary depletion method, which indicates that scFv protein can permeate through the blood brain barrier by mediation of the TfR receptor. Our works lay the foundation for the treatment of tumors and central nervous system diseases.
Collapse
Affiliation(s)
- Li-Xia Zhao
- Beijing Institute of Biotechnology, Beijing 100071, China
| | | | | | | | | | | | | | | |
Collapse
|
18
|
Padiolleau-Lefèvre S, Débat H, Phichith D, Thomas D, Friboulet A, Avalle B. Expression of a functional scFv fragment of an anti-idiotypic antibody with a β-lactam hydrolytic activity. Immunol Lett 2006; 103:39-44. [PMID: 16325271 DOI: 10.1016/j.imlet.2005.10.010] [Citation(s) in RCA: 22] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/05/2005] [Revised: 10/05/2005] [Accepted: 10/09/2005] [Indexed: 11/24/2022]
Abstract
The single chain variable fragment (scFv) of an anti-idiotypic catalytic monoclonal antibody, 9G4H9, displaying a beta-lactamase-like activity was cloned. The recombinant protein was expressed through the periplasm in Escherichia coli in the presence or in the absence of FkpA, a chaperone-like enzyme and tested for its hydrolytic activity. The results show that the catalytic parameters for hydrolysis of ampicillin by scFv9G4H9 are clearly influenced by the presence of FkpA, indicating that the correct folding of the fragment represents a crucial step for catalysis.
Collapse
MESH Headings
- Antibodies, Anti-Idiotypic/genetics
- Antibodies, Anti-Idiotypic/isolation & purification
- Antibodies, Anti-Idiotypic/metabolism
- Antibodies, Catalytic/genetics
- Antibodies, Catalytic/isolation & purification
- Antibodies, Catalytic/metabolism
- Antibodies, Monoclonal/genetics
- Antibodies, Monoclonal/isolation & purification
- Antibodies, Monoclonal/metabolism
- Binding Sites
- Cloning, Molecular
- Hydrolysis
- Immunoglobulin Fc Fragments/genetics
- Immunoglobulin Fc Fragments/isolation & purification
- Immunoglobulin Fc Fragments/metabolism
- Models, Molecular
- Molecular Mimicry
- beta-Lactamases/chemistry
- beta-Lactamases/metabolism
Collapse
Affiliation(s)
- Séverine Padiolleau-Lefèvre
- Génie Enzymatique et Cellulaire, UMR 6022 CNRS, Université de Technologie de Compiègne, BP 20529, 60205 Compiègne Cedex, France
| | | | | | | | | | | |
Collapse
|
19
|
Mi J, Yan J, Guo Z, Zhao M, Chang W. Isolation and characterization of an anti-recombinant erythropoietin single-chain antibody fragment using a phage display antibody library. Anal Bioanal Chem 2005; 383:218-23. [PMID: 16158293 DOI: 10.1007/s00216-005-3401-3] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/29/2005] [Revised: 06/10/2005] [Accepted: 06/15/2005] [Indexed: 11/26/2022]
Abstract
The production of a large amount of specific antibodies against erythropoietin (EPO) is necessary for both clinical treatment and doping control. However, the weak immunogenicity of EPO and the side effects of excessive injection make the conventional immunological protocol rather inefficient and time-consuming. In this study, a single-chain antibody fragment of variable region (scFv) against recombinant human erythropoietin (rHuEPO) was produced after three rounds of panning a phage display antibody library. The selected scFv-B2 was expressed in soluble form in Escherichia coli DH5alpha F' and purified by His-bond nickel affinity chromatography with a yield of about 1-2 mg of antibody in 1 L of the culture supernatant. The molecular weight of the scFv was estimated to be 29 kDa by sodium dodecyl sulfate polyacrylamide gel electrophoresis and the affinity constant was found to be 1.0 x 10(8) L mol(-1) based on a competitive indirect enzyme-linked immunosorbent assay (CI-ELISA). The potential ability of the scFvs for immunopurification of rHuEPO from related sample was demonstrated by using a double-antibody sandwich ELISA. The reported method is a very powerful tool to produce specific antibodies for rHuEPO detection demands.
Collapse
Affiliation(s)
- Jiebo Mi
- Institute of Analytical Chemistry, College of Chemistry and Molecular Engineering, Peking University, Beijing 100871, P R China
| | | | | | | | | |
Collapse
|
20
|
Jelezarova E, Lutz HU. IgG naturally occurring antibodies stabilize and promote the generation of the alternative complement pathway C3 convertase. Mol Immunol 2005; 42:1393-403. [PMID: 15950735 DOI: 10.1016/j.molimm.2004.12.014] [Citation(s) in RCA: 13] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/15/2004] [Accepted: 12/22/2004] [Indexed: 10/25/2022]
Abstract
Normal human IgG contains naturally occurring anti-C3 antibodies (anti-C3 NAbs) that have been proposed to regulate complement amplification. Here, we report a novel procedure for anti-C3 NAb purification. Pooled human IgG was fractionated on a DEAE column prior to affinity chromatography on IgG and then on C3. Anti-C3 NAbs co-purified with anti-F(ab')2 NAbs. In a refined protocol, IgG fractions were absorbed on Fc, F(ab')2, and C3, which allowed to isolate the directly accessible NAbs and to remove IgG hinge-region-specific NAbs. Since a substantial fraction of total anti-C3 NAbs in whole IgG pre-existed as complexes, IgG that did not bind to the three affinity columns was treated with urea and the affinity chromatography repeated to collect the dissociated NAbs. The urea-accessible anti-F(ab')2 NAbs were rather pure but anti-C3 NAbs yet contained substantial amounts of anti-F(ab')2 NAbs. Anti-C3 NAbs showed up to 400-fold and anti-F(ab')2 NAbs, up to 30-fold enrichment as compared to pooled normal human IgG. Anti-C3 NAb preparations exhibited nephritic factor activity that was up to 60 times stronger than that of total IgG from a patient with membranoproliferative glomerulonephritis type 2. In addition, anti-C3 NAbs promoted C3 convertase generation, when added to the convertase precursor or during convertase assembly, suggesting a non-nephritic-factor mechanism. Factors H and I reduced the overall level of activity but had no influence on the NAb dose-response curve meaning that NAbs did not interfere with factor H binding. Convertase promoting activity during assembly correlated with the content of anti-C3 NAbs in NAb complexes. In conclusion, anti-C3 NAbs associated with framework-specific anti-idiotypic NAbs stabilize C3 convertase and promote its generation but their activity is compensated for in whole IgG.
Collapse
Affiliation(s)
- Emiliana Jelezarova
- Institute of Biochemistry, Swiss Federal Institute of Technology, ETH Hoenggerberg, HPM D14, Schafmattstrasse 18, CH-8093 Zurich, Switzerland
| | | |
Collapse
|
21
|
Li B, Peng J, Niu Z, Yin X, Liu F. Preparation of anti-idiotypic antibody against avian influenza virus subtype H9. Cell Mol Immunol 2005; 2:155-7. [PMID: 16191424] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/04/2023] Open
Abstract
To generate monoclonal anti-idiotypic antibodies (mAb2) against avian influenza virus subtype H9 (H9 AIV), BALB/c mice were immunized with purified chicken anti-H9-AIV IgG and the splenocytes of immunized mice were fused with myeloma cells NS-1. Hybridoma cells were screened by indirect enzyme-linked immunosorbent assays with both chicken and rabbit anti-H9-AIV IgG as coating antigens. One hybridoma cell clone secreting monoclonal antibody against idiotypes shared by both chicken and rabbit anti-H9-AIV IgG was established. Experiments demonstrated the mAb2 was able to inhibit the binding of hemagglutinin to anti-H9-AIV IgG and to induce chickens to generate hemagglutination inhibition antibodies, indicating this anti-species-sharing-idiotypic antibody bore the internal image of hemagglutinin on avian influenza virus.
Collapse
Affiliation(s)
- Baoquan Li
- College of Animal Science and Technology, Shandong Agricultural University, Tai'an, China
| | | | | | | | | |
Collapse
|
22
|
Zhang W, Reichlin M. Production and characterization of a human monoclonal anti-idiotype to anti-ribosomal P antibodies. Clin Immunol 2005; 114:130-6. [PMID: 15639646 DOI: 10.1016/j.clim.2004.03.015] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/29/2003] [Accepted: 03/02/2004] [Indexed: 11/18/2022]
Abstract
Autoantibodies to ribosomal P protein (anti-P) are a specific hallmark of systemic lupus erythematous (SLE). Several authors found significant associations of anti-P antibodies with neuropsychiatric, hepatic, and renal disease. We now report the isolation by phage display of human anti-idiotype (Id) monoclonal antibody fragments as single-chain Fv fragment (scFv) against anti-P antibodies. The V gene repertoires were derived from the RNA obtained from the B cells of a SLE patient. Affinity-purified anti-P antibodies were used for the selection of bacterial clones producing anti-P-specific scFv antibody fragments and little reactivity with normal IgG and other IgG antibodies. The anti-Id antibody recognizes a public idiotope broadly cross-reactive with polyclonal anti-P antibodies and inhibited binding of anti-P to ribosomal P antigen in immunoassays and on Jurkat cells. The anti-Id scFv antibody fragment may have therapeutic implications in SLE. They may also be used as probes in the study of the structure of the idiotype.
Collapse
Affiliation(s)
- Wei Zhang
- Arthritis and Immunology Program, Oklahoma Medical Research Foundation, Oklahoma City, OK 73104, USA
| | | |
Collapse
|
23
|
Ranzolin A, Bohn JM, Norman GL, Manenti E, Bodanese LC, von Mühlen CA, Staub HL. Anti-beta2-glycoprotein I antibodies as risk factors for acute myocardial infarction. Arq Bras Cardiol 2004; 83:141-4; 137-40. [PMID: 15322656 DOI: 10.1590/s0066-782x2004001400005] [Citation(s) in RCA: 12] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022] Open
Abstract
OBJECTIVE To determine whether high levels of antibodies against the phospholipid beta2-glycoprotein I (beta2-gpI) cofactor are associated with an increase in the risk of acute myocardial infarction. METHODS The study comprised 82 patients with acute myocardial infarction and 82 controls, who were assessed in regard to age, sex, race, hypertension, smoking, previous heart disease, history of diabetes mellitus, and hypercholesterolemia. The following antibodies were detected using immunoassay: anticardiolipin and anti-beta2-gpI IgA, IgG, and IgM. Adjusted odds ratios (OR) for risk factors were obtained through logistic regression. RESULTS The mean ages of the cases and controls were, respectively, 57.7 and 51.1 years (P=0.003). Men (P=0.005) and the white race predominated in both groups (P=0.798). Of the risk factors, a history of diabetes (OR=5.3; 95% CI: 1.9 to 14.9; P=0.001) and previous heart disease (OR=4.7; 95% CI: 2.0 to 10.7; P<0.001) were the most consistent associations with myocardial infarction. The frequency of anticardiolipin IgG, IgM, and IgA antibodies did not differ between cases and controls (P=1.000). Anti-beta2-gpI IgA antibodies were more frequent in cases than in controls (P=0.054). The adjusted OR for anti-beta2-gpI IgA antibodies was 3.4 (95% CI: 1.3 to 9.1; P=0.015). CONCLUSION Anti-beta2-gpI IgA antibodies, but not anticardiolipin antibodies, seemed to behave as independent risk factors for myocardial infarction, which may represent a link between autoimmunity and atherosclerosis in patients with acute myocardial infarction.
Collapse
|
24
|
Yildirim T, Başalp A, Yücel F, Manav AI, Sezen IY. Generation of Anti-Idiotypic Antibodies that Mimic HBsAg and Vaccination against Hepatitis B Virus. ACTA ACUST UNITED AC 2004; 23:192-7. [PMID: 15312311 DOI: 10.1089/1536859041224307] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022]
Abstract
The advent of hybridoma technology has opened up a new avenue in vaccine development, and antigen-mimicking properties of anti-idiotypic antibodies have provided promising alternatives in the generation of experimental anti-idiotypic vaccines. In the present study, mice were immunized with anti-hepatitis B virus (HBV) mouse monoclonal and anti-HBV goat polyclonal antibody to produce anti-idiotypic antibodies. Two mouse monoclonal antibodies (6C9, 6H9) were obtained from the fusions, and the immunogenic properties and specificity of antibodies were analyzed. BALB/c mice were immunized with varying concentrations of anti-idiotypic antibodies (25, 50, 75, and 100 micrograms of anti-Id), and it was shown that anti-idiotypic antibodies generated hepatitis B surface antigen (HBsAg), as well as a BSA-specific antibody response. A simple method for the purification of monoclonal antibodies by dialyzing antibody against water has also been reported.
Collapse
Affiliation(s)
- Tuba Yildirim
- Gebze Institute of Technology, Gebze, Kocaeli, Turkey
| | | | | | | | | |
Collapse
|
25
|
Jiménez F, Demaría JL, Ahumada C, Nagel A, Baroni MR, Giugni MC, Méndez E. [Seroprevalence of Helicobacter pylori anti-CagA antibodies and its relationship with epidemiologic factors in Santa Fe]. Acta Gastroenterol Latinoam 2004; 34:16-20. [PMID: 15328663] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 04/30/2023]
Abstract
The early detection of anti-CagA antibodies in young adults would be of a great clinical impact in the prevention of gastric cancer. The aim of this study was to assess IgG and anti-CagA antibodies seroprevalence against Helicobacter pylori in our region using a non invasive technique, easy to perform an evaluating its relationship with different epidemiological risk factors. Four hundred and thirty-five volunteers with a mean age of forty years old from different health centers were included in this study. Demographic socieconomical and other data of interest were recorded. IgG and CagA antibodies against Helicobacter pylori were determined using an enzyme immunoassay technique. The prevalence of IgG antibodies was 52.2% being 152 in women (53.7%) and 75 in men (49%). These antibodies were showed in 65% of affected patients and 43.1% in asymptomatic carriers. The prevalence anti-CagA antibodies was 63.4% among seropositives (IgG) individuals corresponding to 33.1% of the total studied population. Ninety-six (33.9%) persons of this group were women an 48 (31.6%) were men. The prevalence was 45.4% and 25.7% in symptomatic an asymptomatic individuals, respectively. It was demonstrated that IgG antibodies were associated with age, area of residence, educational level reached and number of bedrooms in the house. The anti-CagA antibodies depend on area of residence and symptoms. The relation between the symptoms and the presence of anti-CagA antibodies shows the selective importance of clinical data in the gastric diseases associated with Helicobacter pylori.
Collapse
Affiliation(s)
- Felix Jiménez
- Sección gastroenterología, Hospital José María Cullen, Santa Fe, Republica Argentina
| | | | | | | | | | | | | |
Collapse
|
26
|
MESH Headings
- Animals
- Antibodies, Anti-Idiotypic/immunology
- Antibodies, Anti-Idiotypic/isolation & purification
- Antibodies, Monoclonal/immunology
- Antibodies, Monoclonal/isolation & purification
- Antibody Specificity
- Chromatography, Affinity/methods
- Chromatography, Gel/methods
- Cross Reactions
- Female
- Freund's Adjuvant
- Immunoglobulin Fab Fragments/isolation & purification
- Indicators and Reagents
- Ligands
- Mice
- Mice, Inbred BALB C/immunology
- Narcotics/chemistry
- Narcotics/metabolism
- Neurons/metabolism
- Protein Binding
- Radioimmunoassay/methods
- Receptors, Opioid/analysis
- Receptors, Opioid/metabolism
- Serum Albumin, Bovine
Collapse
Affiliation(s)
- J A Glasel
- Department of Biochemistry, University of Connecticut Health Center, Farmington, USA
| | | |
Collapse
|
27
|
Bruley-Rosset M, Mouthon L, Chanseaud Y, Dhainaut F, Lirochon J, Bourel D. Polyreactive autoantibodies purified from human intravenous immunoglobulins prevent the development of experimental autoimmune diseases. J Transl Med 2003; 83:1013-23. [PMID: 12861041 DOI: 10.1097/01.lab.0000077982.70800.02] [Citation(s) in RCA: 24] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022] Open
Abstract
Intravenous immunoglobulins (IVIg) are therapeutic preparations of normal human polyclonal Ig G (IgG) that exert immunomodulatory effects in patients with autoimmune or systemic inflammatory diseases. Two different IgG subfractions were evaluated for their respective immunomodulatory effects in the treatment of experimental autoimmune diseases: a fraction enriched in antibodies that recognize the F(ab')(2) portion of IVIg and a fraction of natural polyreactive autoantibodies purified on a dinitrophenyl (DNP)-Affiprep immunoadsorbent. A very small fraction of IgG interacting with DNP but not with F(ab')(2) fragments expressed an increased ability to bind to self-antigens. The anti-DNP fraction, but not the anti-idiotype fraction, protected against inflammation observed in collagen-induced arthritis and experimental autoimmune encephalomyelitis in rats. Furthermore, it was able to reduce the occurrence of spontaneous diabetes mellitus in nonobese diabetic mice at lower concentrations than unfractionated IVIg. The therapeutic benefit of the anti-DNP fraction was associated with the inhibition of secretion of proinflammatory cytokines and stimulation of secretion of IL-1 receptor antagonist. Our results provide evidence that polyreactive autoantibodies play a role in the protective effect of IVIg in experimental models of autoimmune diseases in which inflammatory reactions are part of the disease process.
Collapse
MESH Headings
- Animals
- Antibodies, Anti-Idiotypic/immunology
- Antibodies, Anti-Idiotypic/isolation & purification
- Arthritis, Experimental/immunology
- Arthritis, Experimental/prevention & control
- Cells, Cultured
- Cross Reactions
- Diabetes Mellitus, Type 1/genetics
- Diabetes Mellitus, Type 1/immunology
- Diabetes Mellitus, Type 1/prevention & control
- Dinitrobenzenes/immunology
- Dose-Response Relationship, Drug
- Encephalomyelitis, Autoimmune, Experimental/immunology
- Encephalomyelitis, Autoimmune, Experimental/prevention & control
- Female
- Humans
- Immunoglobulin Fab Fragments/immunology
- Immunoglobulin G/therapeutic use
- Immunoglobulins, Intravenous/chemistry
- Male
- Mice
- Mice, Inbred NOD
- Polylysine/analogs & derivatives
- Polylysine/immunology
- Rats
- Rats, Inbred Lew
Collapse
|
28
|
Abstract
We prepared six anti-idiotypic monoclonal antibodies (mAbs) against parent 41S-2 mAb whose light chain is a super catalytic antibody (41S-2-L) capable of degrading targeted HIV-1gp41 molecule. Out of the obtained six mAbs, i41-7 mAb showed the strongest affinity to the parent 41S-2 mAb. The three dimensional structure of i41-7 mAb was created by molecular modeling using the deduced amino acid sequence of the light and heavy chain of i41-7 mAb. It suggests that the light and heavy chain possess catalytic triad-like structure composed of Ser, His and Asp in their conformations. Both chains of i41-7 mAb could cleave peptide bond of some peptides such as a polypeptide, TP41-1 (TPRGPDRPEGIEEEGGERDRD), as anticipated. The cleaving reaction advanced in accordance with Michaelis-Menten equation. The catalytic efficiency (kcat/Km) of light and heavy chain was 9.1 x 10(3) and 1.7 x 10(4) M(-1) x min(-1), respectively, while the intact i41-7 mAb did not exhibit any catalytic activity. The first cleaved bond of the TP41-1 peptide by the light chain was between 14E and 15G in the sequence. It was revealed that both light and heavy chains had endopeptidase characteristics.
Collapse
MESH Headings
- Animals
- Antibodies, Anti-Idiotypic/biosynthesis
- Antibodies, Anti-Idiotypic/chemistry
- Antibodies, Anti-Idiotypic/isolation & purification
- Antibodies, Catalytic/biosynthesis
- Antibodies, Catalytic/chemistry
- Antibodies, Catalytic/isolation & purification
- Antibodies, Monoclonal/biosynthesis
- Antibodies, Monoclonal/chemistry
- Antibodies, Monoclonal/isolation & purification
- Antibody Specificity
- Catalytic Domain/physiology
- Chromatography, High Pressure Liquid
- Endopeptidases
- Enzyme-Linked Immunosorbent Assay
- HIV Envelope Protein gp41/metabolism
- Hybridomas
- Immunoglobulin Heavy Chains/chemistry
- Immunoglobulin Heavy Chains/isolation & purification
- Immunoglobulin Light Chains/chemistry
- Immunoglobulin Light Chains/isolation & purification
- Immunoglobulin Light Chains/metabolism
- Models, Molecular
- Protein Structure, Quaternary
Collapse
Affiliation(s)
- Kenji Hatiuchi
- School of Biosciences, Hiroshima Prefectural University, Shobara City 727-0023, Japan
| | | | | | | |
Collapse
|
29
|
Gabibov AG, Friboulet A, Thomas D, Demin AV, Ponomarenko NA, Vorobiev II, Pillet D, Paon M, Alexandrova ES, Telegin GB, Reshetnyak AV, Grigorieva OV, Gnuchev NV, Malishkin KA, Genkin DD. Antibody proteases: induction of catalytic response. Biochemistry (Mosc) 2002; 67:1168-79. [PMID: 12460115 DOI: 10.1023/a:1020971509138] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
Abstract
Most of the data accumulated throughout the years on investigation of catalytic antibodies indicate that their production increases on the background of autoimmune abnormalities. The different approaches to induction of catalytic response toward recombinant gp120 HIV-1 surface protein in mice with various autoimmune pathologies are described. The peptidylphosphonate conjugate containing structural part of gp120 molecule is used for reactive immunization of NZB/NZW F1, MRL, and SJL mice. The specific modification of heavy and light chains of mouse autoantibodies with Val-Ala-Glu-Glu-Glu-Val-PO(OPh)2 reactive peptide was demonstrated. Increased proteolytic activity of polyclonal antibodies in SJL mice encouraged us to investigate the production of antigen-specific catalytic antibodies on the background of induced experimental autoimmune encephalomyelitis (EAE). The immunization of autoimmune-prone mice with the engineered fusions containing the fragments of gp120 and encephalitogenic epitope of myelin basic protein (MBP(89-104)) was made. The proteolytic activity of polyclonal antibodies isolated from the sera of autoimmune mice immunized by the described antigen was shown. Specific immune response of SJL mice to these antigens was characterized. Polyclonal antibodies purified from sera of the immunized animals revealed proteolytic activity. The antiidiotypic approach to raise the specific proteolytic antibody as an "internal image" of protease is described. The "second order" monoclonal antibodies toward subtilisin Carlsberg revealed pronounced proteolytic activity.
Collapse
Affiliation(s)
- A G Gabibov
- Shemyakin and Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, Moscow, 117198 Russia.
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
30
|
Abstract
Anti-dsDNA autoantibodies are the hallmark of systemic lupus erythematosus (SLE) and frequently correlate with disease activity. In this study we report the isolation and characterization of human anti-Id monoclonal antibody fragments as single-chain Fv fragments (scFv) against anti-dsDNA antibody. The anti-Id monoclonal antibodies, specific for anti-dsDNA antibodies, have been cloned from phage display antibody scFv libraries derived from a patient with SLE. The V gene repertoires were derived from the RNA obtained from the B cells of an SLE patient with anti-Ro/SSA and anti-La/SSB antibodies. Affinity-purified anti-dsDNA antibodies were used for selection of bacterial clones producing specific scFv antibody fragments against anti-dsDNA antibodies and little reactivity with normal IgG and other IgG antibodies by ELISA. The anti-Id antibody recognizes a public idiotope that is broadly cross-reactive with polyclonal and monoclonal anti-dsDNA antibodies. This binding was largely inhibited by dsDNA antigen. The anti-Id antibody inhibited anti-dsDNA binding to dsDNA antigen in immunoassays and in the Crithidia luciliae assay. The anti-Id scFv antibody fragments derived from human genes could modulate the pathogenicity of anti-dsDNA autoantibodies and may have therapeutic implications in SLE. They may also be used as probes in studies of the structure of the idiotype.
Collapse
MESH Headings
- Animals
- Antibodies, Anti-Idiotypic/biosynthesis
- Antibodies, Anti-Idiotypic/genetics
- Antibodies, Anti-Idiotypic/isolation & purification
- Antibodies, Antinuclear/immunology
- Antibodies, Monoclonal/biosynthesis
- Antibodies, Monoclonal/genetics
- Antibodies, Monoclonal/isolation & purification
- Crithidia
- Fluorescent Antibody Technique, Indirect
- Humans
- Immunoglobulin Fragments/biosynthesis
- Immunoglobulin Fragments/genetics
- Immunoglobulin Fragments/isolation & purification
- Immunotherapy
- Lupus Erythematosus, Systemic/immunology
- Lupus Erythematosus, Systemic/therapy
- Peptide Library
Collapse
Affiliation(s)
- W Zhang
- Oklahoma Medical Research Foundation, Oklahoma City 73104, USA
| | | | | |
Collapse
|
31
|
Kwon MH, Lee MS, Kim KH, Park S, Shin HJ, Jang YJ, Kim HI. Production and characterization of an anti-idiotypic single chain Fv that recognizes an anti-DNA antibody. Immunol Invest 2002; 31:205-18. [PMID: 12472180 DOI: 10.1081/imm-120016241] [Citation(s) in RCA: 20] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
Abstract
A well-characterized recombinant anti-idiotype to an anti-DNA antibody can be useful for studies of the regulation of anti-DNA-producing B cells. Using a hybridoma technique, a monoclonal anti-idiotypic antibody, designated O2F3, was obtained, and its scFv gene was constructed. O2F3 single chain Fv (scFv) was produced against an idiotope of a monoclonal anti-DNA antibody, 3D8, that was obtained from an autoimmune-prone mouse, MRL-lpr/lpr. Here we describe the production and in vitro characterization of the O2F3 scFv, and compare it with its parent monoclonal antibody, O2F3 IgM. To characterize O2F3 scFv and O2F3 IgM, we generated recombinant 3D8 fragments, including 3D8 scFv, 3D8 VH, and 3D8 VL, that were used as antigens in several assays. ELISA and Western blot analysis showed that both O2F3 scFv and O2F3 IgM recognized a conformational determinant formed by the association of the variable region heavy and light chains of the 3D8 antibody, suggesting that O2F3 scFv retained a similar binding pattern to its parent O2F3 antibody. The idiotope recognized by O2F3 was shown by competitive ELISA to be outside of the DNA binding site of the 3D8 antibody. This characterized O2F3 scFv could be applied for the regulation of anti-DNA antibody production and the manipulation of recombinant antibody-based proteins to which toxins, enzymes, and chemical agents can be connected.
Collapse
MESH Headings
- Animals
- Antibodies, Anti-Idiotypic/biosynthesis
- Antibodies, Anti-Idiotypic/genetics
- Antibodies, Anti-Idiotypic/immunology
- Antibodies, Anti-Idiotypic/isolation & purification
- Antibodies, Antinuclear/chemistry
- Antibodies, Antinuclear/immunology
- Antibodies, Monoclonal/biosynthesis
- Antibodies, Monoclonal/genetics
- Antibodies, Monoclonal/immunology
- Antibodies, Monoclonal/isolation & purification
- Autoantigens/immunology
- Autoimmune Diseases/immunology
- Binding Sites
- Binding, Competitive
- DNA/immunology
- DNA, Single-Stranded/chemistry
- DNA, Single-Stranded/immunology
- Enzyme-Linked Immunosorbent Assay
- Epitopes/chemistry
- Epitopes/immunology
- Female
- Genes, Immunoglobulin
- Genetic Vectors/genetics
- Hybridomas/immunology
- Immunoglobulin Fragments/biosynthesis
- Immunoglobulin Fragments/genetics
- Immunoglobulin Fragments/immunology
- Immunoglobulin Fragments/isolation & purification
- Immunoglobulin Idiotypes/chemistry
- Immunoglobulin Idiotypes/immunology
- Immunoglobulin M/biosynthesis
- Immunoglobulin M/genetics
- Immunoglobulin M/immunology
- Immunoglobulin M/isolation & purification
- Lupus Erythematosus, Systemic/immunology
- Mice
- Mice, Inbred BALB C
- Mice, Inbred MRL lpr
- Protein Conformation
- Recombinant Fusion Proteins/immunology
Collapse
Affiliation(s)
- Myung-Hee Kwon
- Department of Microbiology, Ajou University School of Medicine, Woncheon-dong 5, Suwon 442-749, Korea
| | | | | | | | | | | | | |
Collapse
|
32
|
Debiec H, Guigonis V, Mougenot B, Decobert F, Haymann JP, Bensman A, Deschênes G, Ronco PM. Antenatal membranous glomerulonephritis due to anti-neutral endopeptidase antibodies. N Engl J Med 2002; 346:2053-60. [PMID: 12087141 DOI: 10.1056/nejmoa012895] [Citation(s) in RCA: 344] [Impact Index Per Article: 15.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/13/2022]
|
33
|
Abstract
This review focusses on affinity purification of immunoglobulins, a methodology which is a powerful tool to obtain pure and intact antibodies. Affinity techniques allow antibody purification both in a single step chromatographic procedure as well as in complex purification protocols depending on the intention to use the target antibody. The purification strategies for antibodies by interaction with affinity ligands such as antibodies and Fe receptors or low molecular weight compounds are described.
Collapse
Affiliation(s)
- Klaus Huse
- Institute of Molecular Biotechnology, Jena, Germany
| | | | | |
Collapse
|
34
|
Tschernia A, LeLeiko NS, Grima K, Whittset C, Molnar K, Spencer RW, Sloves MF, Gondolesi G, Kaufman SS, Fishbein TM. Anti-HLA antibody removal by extracorporeal immunoadsorption in two hyperimmunized pediatric patients awaiting hepatointestinal transplantation. Transplant Proc 2002; 34:900-1. [PMID: 12034228 DOI: 10.1016/s0041-1345(02)02659-3] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
Affiliation(s)
- A Tschernia
- Mount Sinai School of Medicine, New York, New York 10029, USA.
| | | | | | | | | | | | | | | | | | | |
Collapse
|
35
|
Goletz S, Christensen PA, Kristensen P, Blohm D, Tomlinson I, Winter G, Karsten U. Selection of large diversities of antiidiotypic antibody fragments by phage display. J Mol Biol 2002; 315:1087-97. [PMID: 11827478 DOI: 10.1006/jmbi.2001.5314] [Citation(s) in RCA: 98] [Impact Index Per Article: 4.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
Abstract
Antiidiotypic antibodies (Ab2) are needed as tools for a better understanding of molecular mimicry and the immunological network, and for many potential applications in the biomedical and pharmaceutical field. Antiidiotypic antibodies mimicking carbohydrate or conformational epitopes (Ab2beta) are of considerable interest as surrogate immunogens for cancer vaccination. However, it has so far been difficult and tedious to produce Ab2s to a given antigen. Here we describe a fast and reliable technique for generating large diversities of antiidiotypic single chain antibody fragments from non-immunized phagemid libraries using phage display. Key elements are a specific elution with the original antigen followed by trypsin treatment of the eluted phages in combination with the protease sensitive helperphage KM13. This novel method was compared with various conventional selection and elution methods, including, specific elution with or without trypsin treatment, elution with glycine at pH 2.2 with or without trypsin treatment, and elution by trypsin treatment only. The results clearly show that specific elution in combination with trypsin treatment of the eluted phages is by far superior to the other conventional methods, enabling for the first time the generation of a large variety of Ab2s after only two to three rounds of selection, thereby maintaining maximum diversity. We obtained 28 to 88 antiidiotypes out of 96 tested clones after two to three rounds of selection with a diversity of 55-90 %. This was achieved for two carbohydrate (di-, and tetrasaccharides) and one conformational protein epitope using two large naïve libraries and their corresponding monoclonal Ab1. The antiidiotypic nature of the selected scFv-phages was verified by ELISA and immunocytochemistry inhibition experiments.
Collapse
Affiliation(s)
- Steffen Goletz
- NEMOD GmbH, Robert-Rössle-Str. 10, Berlin-Buch, D-13125, FRG.
| | | | | | | | | | | | | |
Collapse
|
36
|
Sostegni R, Daperno M, Ercole E, Rigazio C, Bresso F, Masoero G, Castellino F, Zaffino C, Rocca R, Molinaro GC, Rocca G, Astegiano M, Pera A. Detection of anti-Saccharomyces cerevisiae antibodies in Crohn's disease: is it a reliable diagnostic and prognostic marker? Dig Liver Dis 2001; 33:755-61. [PMID: 11838610 DOI: 10.1016/s1590-8658(01)80692-7] [Citation(s) in RCA: 14] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/11/2022]
Abstract
BACKGROUND In the past few years, serologic markers have been proposed in inflammatory bowel disease. Anti-Saccharomyces cerevisiae antibodies showed high specificity for Crohn's disease. A prognostic role for serology has also been hypothesised. AIMS To evaluate anti-Saccharomyces cerevisiae antibody distribution in an unselected Italian inflammatory bowel disease population. To analyse whether anti-Saccharomyces cerevisiae antibody status (positive/negative) and/or anti-Saccharomyces cerevisiae antibody titres are associated with clinical variables and outcome measures in Crohn's disease patients. PATIENTS AND METHODS A series of 299 inflammatory bowel disease patients were evaluated; serum samples were taken and a short clinical history was recorded. anti-Saccharomyces cerevisiae antibodies IgG enzyme-linked immunosorbent assay Medilab (Milan, Italy) kit was used in order to determine anti-Saccharomyces cerevisiae antibody status. RESULTS Sensitivity, specificity and likelihood ratio for positive test in the differential diagnosis of inflammatory bowel disease was 59%, 89%, 8.1, respectively. Clinical variables significantly associated with anti-Saccharomyces cerevisiae antibody status in logistic regression were found to be ileal location (p=0.01) and earlier age at diagnosis (p<0.01). Among ileal Crohn's disease patients, there was a trend in concordance between anti-Saccharomyces cerevisiae antibody titres and higher number of surgical procedures which was not statistically significant applying more complex statistics. CONCLUSIONS In an Italian inflammatory bowel disease population, anti-Saccharomyces cerevisiae antibodies status showed characteristics similar to those previously reported. Anti-Saccharomyces cerevisiae antibody positivity is associated with ileal involvement and with earlier onset of Crohn's disease.
Collapse
Affiliation(s)
- R Sostegni
- Gastroenterology Unit, Ospedale Mauriziano Umberto I, Torino, Italy
| | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
37
|
Sakuma Y, Uchida H, Nagai H, Kobayashi E. High-dose tacrolimus and lengthy survival of the combined rat pancreas/spleen graft in a high-responder combination. Transpl Immunol 2001; 9:37-42. [PMID: 11680570 DOI: 10.1016/s0966-3274(01)00049-1] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/04/2023]
Abstract
Pancreas grafts do not survive for lengthy periods, especially in a high-responder rat combination. Recent data indicated that a combined spleen/pancreas graft protects against acute graft rejection and induces donor-specific tolerance. In this study, we performed a combination spleen/pancreas transplantation using high-dose tacrolimus in a high-responder rat combination of DA (RT1a) to LEW (RT1) and induced permanent survival in the few recipient rats. In these recipients, there was no difference in the mixed lymphocyte reaction (MLR) of the recipients when compared with that of the naive LEW splenic cells, but MLR inhibition by the serum from the recipients was significantly decreased. We also performed immunoblotting and detected a protein that has an affinity for the anti-DA class antibody. This protein may be an anti-idiotypic antibody and contribute to donor- and tissue-specific tolerance.
Collapse
Affiliation(s)
- Y Sakuma
- Department of General Surgery, Jichi Medical School, Yakushiji Minamikawachi, Tochigi, Japan
| | | | | | | |
Collapse
|
38
|
Abstract
The anti-idiotypic (Id) monoclonal antibody (MAb) 520C9-6b (IgG1k), raised in syngenic mice against the murine anti-Her2/neu MAb 520C9 (Ab1), functionally mimics a human Her2/neu epitope and serves as a surrogate for the protein antigen. Immunization of allogeneic C57BL/6 mice and rabbits with 520C9-6b (Ab2) induced anti-Her2/neu-specific antibodies that react with antigen-positive SKBr3 cells by ELISA and FACS analysis. The immune sera inhibited binding between Ab1 and Ab2 and vice versa (binding of Ab2 to Ab1), indicating that it was a true anti-anti-Id (Ab3) antibody. The Ab3 sera or purified Ab3 specifically lysed Her2/neu-positive SKBr3 cells, but no significant lysis was observed in antigen-negative LS174T cells in an antibody-dependent cellular cytotoxicity assay. An Id-specific cellular immune response was also demonstrated in an in vitro lymphocyte proliferation assay. Furthermore, a panel of tumor tissues and tumor cells was screened for the presence of the Her2/neu epitope by its reactivity with Ab1 and Ab3 using immunohistochemistry and FACS analysis. Identical results were obtained using either Ab1 or Ab3 (Ab1'). The data indicated that anti-Id 520C9-6b can induce Her2/neu-specific antibody in experimental animals and may serve as a potential network antigen for the treatment of patients bearing Her2/neu-positive tumors.
Collapse
MESH Headings
- Animals
- Antibodies, Anti-Idiotypic/immunology
- Antibodies, Anti-Idiotypic/isolation & purification
- Antibodies, Monoclonal/immunology
- Antibodies, Monoclonal/isolation & purification
- Antibody-Dependent Cell Cytotoxicity
- Antigens/immunology
- Antigens, Neoplasm/immunology
- Breast Neoplasms/immunology
- Enzyme-Linked Immunosorbent Assay
- Female
- Flow Cytometry
- Humans
- Hybridomas/immunology
- Immune Sera/pharmacology
- Immunity, Cellular
- Immunization
- Lymphocyte Activation
- Mice
- Mice, Inbred BALB C
- Mice, Inbred C57BL
- Rabbits
- Receptor, ErbB-2/immunology
- T-Lymphocytes/immunology
- Tumor Cells, Cultured
Collapse
Affiliation(s)
- R Baral
- Division of Hematology/Oncology, Department of Internal Medicine and The Barrett Cancer Center for Prevention, Treatment and Research, University of Cincinnati, OH 45267-0509, USA
| | | | | | | | | |
Collapse
|
39
|
Zhang W, Winkler T, Kalden JR, Reichlin M. Isolation of human anti-idiotypes broadly cross reactive with anti-dsDNA antibodies from patients with Systemic lupus erythematosus. Scand J Immunol 2001; 53:192-7. [PMID: 11169224 DOI: 10.1046/j.1365-3083.2001.00858.x] [Citation(s) in RCA: 12] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]
Abstract
Antibodies to double stranded (ds)DNA play a central role in clinical diagnosis and disease expression in Systemic lupus erythematosus (SLE). This paper describes the isolation of anti-idiotype reagents (anti/antidsDNA) from four SLE sera and the demonstration of broad and quantitatively similar cross reactivity to both polyclonal and monoclonal anti-dsDNA antibodies isolated from SLE patients. Seven affinity-purified polyclonal and three monoclonal human anti-dsDNA preparations reacted preferentially with anti-idiotype F(ab')(2) coated plates compared to normal immunoglobulin (Ig)G F(ab')(2) coated plates in ELISA. In contrast, autoantibodies of other specificities (anti-Ro/SSA, anti-La/SSB, and anti-U(1)RNP) reacted equally with anti/anti-dsDNA F(ab')(2) and normal IgG F(ab')(2) coated plates. Such anti-idiotypic antibodies could play a significant role in the regulation of anti-dsDNA antibody levels in SLE.
Collapse
MESH Headings
- Antibodies, Anti-Idiotypic/blood
- Antibodies, Anti-Idiotypic/immunology
- Antibodies, Anti-Idiotypic/isolation & purification
- Antibodies, Antinuclear/immunology
- Antibodies, Monoclonal/immunology
- Antibody Specificity
- Antigen-Antibody Reactions
- Autoantigens/immunology
- Autoimmune Diseases/blood
- Autoimmune Diseases/immunology
- Chromatography, Affinity
- Cross Reactions
- DNA/immunology
- Humans
- Immunoglobulin Fab Fragments/immunology
- Immunoglobulin G/blood
- Immunoglobulin G/immunology
- Immunoglobulin G/isolation & purification
- Lupus Erythematosus, Systemic/blood
- Lupus Erythematosus, Systemic/immunology
- RNA, Small Cytoplasmic
- Ribonucleoprotein, U1 Small Nuclear/immunology
- Ribonucleoproteins/immunology
- SS-B Antigen
Collapse
Affiliation(s)
- W Zhang
- Arthritis & Immunology Program, Oklahoma Medical Research Foundation, Oklahoma University Health Sciences Center, Oklahoma City, OK 73104, USA
| | | | | | | |
Collapse
|
40
|
Abstract
We perform a retrospective study to determine the incidence and characteristics of alloimmunization in Chinese patients with warm autoimmune haemolytic anaemia. Among 67 patients studied, clinically significant alloantibodies were found in only eight patients, giving a rate of alloimmunization of 11.3%. The latter contrasts with the much higher rate reported in the Western population. This probably reflects the genetic homogeneity in Chinese with respect to the red cell phenotype. The alloimmunization rate, however, is still significant and therefore comprehensive pretransfusion testing is required for Chinese patients with warm autoantibodies so as to safeguard patient's safety.
Collapse
Affiliation(s)
- C C So
- Department of Pathology, Queen Elizabeth Hospital, Hong Kong, China.
| | | | | | | | | |
Collapse
|
41
|
Abstract
IgG4 anti-IgG autoantibodies were found to be present in all serum samples from a group of healthy people; IgG4 ant-IgA and anti-IgE were present In only 13 of 218 (6%) and 8 of 218 (3.5%) samples, respectively. These antibodies also showed affinities towards animal immunoglobulins. We suggest that IgG4 anti-IgA antibodies (the strongest found heterophilic Immunoglobulins) are responsible for most artifacts obtained with commercial EUSA systems.
Collapse
|
42
|
Souza AR, Gesztesi JL, del Negro GM, Benard G, Sato J, Santos MV, Abrahão TB, Lopes JD. Anti-idiotypic antibodies in patients with different clinical forms of paracoccidioidomycosis. Clin Diagn Lab Immunol 2000; 7:175-81. [PMID: 10702489 PMCID: PMC95845 DOI: 10.1128/cdli.7.2.175-181.2000] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]
Abstract
Paracoccidioidomycosis (PCM) is the most prevalent systemic mycosis in Latin America. Patients with PCM show a wide spectrum of clinical and pathological manifestations depending on both host and pathogen factors. Two clinical forms of the disease are recognized: the acute or juvenile form and the chronic or adult form. The major antigenic component of the parasite is a glycoprotein of 43 kDa (gp43). All patient sera present antibodies against gp43 (anti-gp43) and, as demonstrated before by our group, spontaneous anti-idiotypic (anti-Id) antibodies (Ab2) can be detected in patient sera with high titers of anti-gp43. Since it has been postulated that anti-Id antibodies may have a modulating function, we decided to purify and characterize anti-Id antibodies in this system. The possible correlation of Ab2 titers with different clinical forms of disease was also verified. Results showed that purified human anti-Id antibodies (human Ab2) recognized specifically the idiotype of some murine monoclonal anti-gp43 (17c and 3e) but not others (40.d7, 27a, and 8a). Spontaneous anti-Id antibodies were found in all clinical forms of disease. The majority of patients (88%, n = 8) with the acute form of PCM had high titers of Ab2. However, among patients with the multifocal chronic form of the disease, only 29% (n = 14) had high titers of Ab2; 70% (n = 10) of patients with the unifocal chronic form had low titers of Ab2. A correlation between Ab2 titers and anti-gp43 titers was observed before and during antimycotic treatment. Our results suggest that titers of anti-Id antibodies correlate with the severity of PCM in humans.
Collapse
Affiliation(s)
- A R Souza
- Discipline of Immunology, Federal University of São Paulo (UNIFESP), São Paulo Brazil
| | | | | | | | | | | | | | | |
Collapse
|
43
|
Abstract
Rabbit anti-idiotypic antibodies (anti-Id-ab) against Yersinia pestis lipopolysaccharide (LPS) were obtained with monoclonal immunoglobulins. Their complementary character to the original antigen was confirmed by immunohistochemical analysis and ELISA and gel precipitation tests. The anti-Id-ab were shown to possess all essential properties of Ab2beta subtype. Both in-vitro and in-vivo experiments demonstrated a pronounced adjuvant activity of anti-Id-ab without the toxic effect characteristic of Y. pestis LPS. Combined immunisation with anti-Id-ab plus the FI capsular antigen led to a significant increase in the protective immune response against experimental acute challenge with virulent Y. pestis.
Collapse
|
44
|
Suzuki Y, Shimada N, Niwa R, Yokoi M, Nakajima M, Murofushi N, Yamaguchi I. Preparation and application of anti-idiotypic antibody against anti-gibberellin A4 antibody. Biosci Biotechnol Biochem 1999; 63:648-54. [PMID: 10361677 DOI: 10.1271/bbb.63.648] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
Abstract
A monoclonal anti-idiotypic antibody was raised against anti-gibberellin A4 (GA4) antibody, which recognizes biologically active gibberellins such as GA1 and GA4 specifically. Amino acid sequences of variable regions of both anti-GA4 and anti-idiotypic antibodies were analyzed. By using the property of the anti-idiotypic antibody to compete with GA1/4 in binding to the anti-GA4 antibody, we successfully applied the anti-idiotypic antibody to ELISA as a tracer for measuring GA1/4. The single-chain Fv (scFv) gene of the anti-idiotypic antibody was constructed, and scFv expressed in E. coli showed binding activity to anti-GA4 antibody. These results suggest the possible application of anti-idiotypic antibody as a handy and stable source of an enzymatic tracer for ELISA by production of fusion protein of the scFv and an appropriate enzyme.
Collapse
Affiliation(s)
- Y Suzuki
- Department of Applied Biological Chemistry, University of Tokyo, Japan.
| | | | | | | | | | | | | |
Collapse
|
45
|
Welschof M, Reineke U, Kleist C, Kipriyanov S, Little M, Volkmer-Engert R, Schneider-Mergener J, Opelz G, Terness P. The antigen binding domain of non-idiotypic human anti-F(ab')2 autoantibodies: study of their interaction with IgG hinge region epitopes. Hum Immunol 1999; 60:282-90. [PMID: 10363719 DOI: 10.1016/s0198-8859(98)00132-3] [Citation(s) in RCA: 17] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
Abstract
In previous studies we described a natural human IgG-anti-F(ab')2 autoantibody family with immunoregulatory properties. Genes coding for the variable regions of the heavy and light chains of the Abs were isolated from a natural Ig gene library and scFv Abs were expressed in E. coli. The scFv Abs bound to F(ab')2 but not to Fab fragments. This points to an epitope located in the hinge region since Fab fragments are lacking most of the hinge. In order to verify our hypothesis, double chain peptides comprising the lower-, middle-, and part of the upper hinge subregion of IgG1-IgG4 were synthesized on cellulose membranes and tested for binding to the Abs. The results show binding of Abs to IgG1 and IgG4 hinge region peptides. In order to identify the key residues of the discontinuous epitopes we carried out complete substitutional analyses in which each amino acid of the wt peptides was substituted by all other amino acids except cysteine. The exchange of proline in the IgG1 or IgG4 middle hinge region abrogated the binding, revealing the importance of this subregion for epitope expression. No binding to the IgG2 or IgG3 hinge was detected. These results indicate that scFv anti-F(ab')2 Abs recognize the hinge region of IgG1 and IgG4 and that the expression of the epitope depends on an intact middle hinge subregion.
Collapse
Affiliation(s)
- M Welschof
- BASF-Lynx Bioscience AG, Heidelberg, Germany
| | | | | | | | | | | | | | | | | |
Collapse
|
46
|
Cahill CM, Rogers JT. Anti-idiotypic sera against monoclonal anti-porcine growth hormone antibodies: production in rabbits and characterization of specificity. J Immunoassay 1999; 20:45-55. [PMID: 10225514 DOI: 10.1080/01971529909349313] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
Abstract
Antisera were raised in rabbits against two mouse monoclonal anti-porcine growth hormone (pGH) antibodies. Anti-idiotypic antibodies were isolated from rabbit sera by successive passage over immunoadsorbent columns of normal mouse Ig (mIg), followed by the specific immunizing monoclonal and elution from the latter. Enzyme linked immunoadsorbent assay (ELISA) for anti-idiotype and free idiotype were established. While showing specificity for their respective inducing monoclonals, anti-idiotypes also cross reacted in varying degrees with other anti-pGH monoclonals regardless of specificity differences between the antibodies, demonstrating the presence of a cross-reactive idiotype.
Collapse
Affiliation(s)
- C M Cahill
- Dept. of Medicine, Massachusetts General Hospital, Boston 02114, USA
| | | |
Collapse
|
47
|
Takahashi M, Tamaki T, Tanaka M, Katori M, Yokota N, Takamine M, Osanai M, Naitoh M, Yasuhara M, Kukita K, Meguro J, Yonekawa M, Kawamura A. Cryofiltration: a new approach for removal of anti-blood group antibody. Transplant Proc 1998; 30:3275-6. [PMID: 9838447 DOI: 10.1016/s0041-1345(98)01026-4] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/16/2022]
Affiliation(s)
- M Takahashi
- Department of Surgery, Sapporo Hokuyu Hospital, Japan
| | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
48
|
Ago K. [Studies on properties of cross-reacting anti-A,B antibodies in group O sera]. Nihon Hoigaku Zasshi 1998; 52:319-30. [PMID: 10077979] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 02/11/2023]
Abstract
It is widely accepted that the sera of group O individuals contain three antibodies: anti-A, anti-B, and an antibody capable of reacting with both A and B red cells, generally called anti-A,B. The exact nature of the anti-A,B antibody, however, has been controversial for a long time. This paper attempts to answer the question of the anti-A,B antibody. The anti-A,B antibody was separated and purified from pooled group O sera by six consecutive runs of affinity chromatography on alternating columns of group A-specific and group B-specific immunoadsorbents. The final eluate, the anti-A,B preparation, was found to be homogeneous in the polyacrylamide gel disc electrophoresis and immunoelectrophoresis. Immunodiffusion studies, together with treatment with 2-mercaptoethanol, showed the anti-A,B antibody to be IgG. The anti-A activity of the anti-A, B antibody was inhibited with group A secretor saliva and group A-specific substances, but not with group B secretor saliva and group B-specific substances, and the anti-B activity of the antibody was inhibited with group B secretor saliva and group B-specific substances, but not with group A secretor saliva and group A-specific substances. Then, Fab fragments of the anti-A,B antibody were prepared by papain digestion. Indirect hemagglutination tests for the Fab fragments by use of an anti-Fab antiserum demonstrated that the Fab fragments possess both of anti-A and anti-B activity. Then, rosetting tests for the anti-A,B antibody were carried out using A- and B-specific trisaccharides covalently attached to silica particles. The results showed that the anti-A,B antibody linked A- and B-specific trisaccharides to A and B red cells. These results strongly indicate that the anti-A,B antibody is an antibody with significant affinity for both group A and group B antigens rather than an antibody directed against a structure common to group A and group B antigens. The conclusions based on the above experiments are that the anti-A,B antibody in group O sera is IgG and presumably possesses dual specificity regarding to anti-A and anti-B activity.
Collapse
Affiliation(s)
- K Ago
- Department of Legal Medicine, Faculty of Medicine, Kagoshima University, Japan
| |
Collapse
|
49
|
Abstract
Techniques currently available to obtain anti-idiotypic reagents reactive with a single chain of a lymphocyte antigen receptor rely on immunization with intact soluble or cell-bound Ig or T-cell receptors. Ready recovery of single-chain-specific monoclonal antibodies (MAbs) depends on the presence of an immunodominant epitope on the desired chain and chance recovery of the responding clone. Here we present a method to maximize recovery of an Ig heavy-chain-specific anti-idiotypic Ig, using sequential immunization with MAbs expressing the H chain V region in combination with different H chain isotypes and with different light chains. The latter was produced by in vitro transfection of an H-chain-loss variant myeloma cell line with a transgene construct expressing the Ig H chain V region of interest. Sequential immunization may be a useful strategy to enhance selection of anti-Id reagents reactive with single chain-specific epitopes.
Collapse
Affiliation(s)
- M H Foster
- Department of Medicine, The University of Pennsylvania School of Medicine, Philadelphia 19104, USA
| | | | | |
Collapse
|
50
|
Affiliation(s)
- Y Frobert
- Section de Pharmacologie et D'Immunologie, Direction des Sciences du Vivant, Gif sur Yvette, France
| | | |
Collapse
|